Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses ————— — Research & development ————— — Operating income 797 M817 M855 M511 M1.07 B 3.26 B Non-Operating Income, Total 312 M-62 M139 M153 M408 M 638 M Interest expense, net of interest capitalized 241 M248 M253 M263 M272 M 1.04 B Non-Operating Income, excl. Interest Expenses 34 M-356 M-153 M-133 M93 M -549 M Unusual income/expense 37 M46 M39 M23 M43 M 151 M Pretax income 617 M726 M720 M311 M848 M 2.6 B Equity in earnings 000—— — Taxes 28 M141 M98 M-4 M107 M 342 M Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 589 M585 M622 M315 M741 M 2.26 B Discontinued operations ————— — Net income 589 M585 M622 M315 M741 M 2.26 B Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 589 M585 M622 M315 M741 M 2.26 B Basic earnings per share (Basic EPS) 1.181.171.250.631.48 4.53 Diluted earnings per share (Diluted EPS) 1.181.171.240.631.48 4.52 Average basic shares outstanding 498 M499 M499 M499 M499 M — Diluted shares outstanding 500 M500 M501 M501 M500 M — EBITDA ————— — EBIT 797 M817 M855 M511 M1.07 B 3.26 B Cost of revenue 1.51 B1.13 B1.44 B1.33 B1.84 B 5.75 B Other cost of goods sold 1.19 B826 M1.13 B1.01 B1.51 B 4.48 B Depreciation & amortization (cash flow) ————— —